Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Ingles Markets Inc (NASDAQ: IMKTA) weakened during the last several trading days. IMKTA’s current Value Trend Rating is C and […]
Stock Rating Upgrade In the last week the Value Trend Rating for Horizon Technology Finance Corp (NASDAQ: HRZN) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action Horizon Technology […]
Hewlett Packard Enterprise Co (NYSE: HPE) stock suffered a major decline of -12.0% on 3/7/25. The shares closed at $15.81. Moreover, trading volume in this decline was exceptionally high at 534% of normal. Relative to […]
Stock Rating Downgrade The Value Trend Rating for Hecla Mining Co (NYSE: HL) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Grupo Aeroportuario Del Pacifico (NYSE: PAC) weakened of late. PAC’s current Value Trend Rating is D and the prior Rating […]
For its fourth fiscal quarter (ending January 31), Genesco Inc. (NYSE: GCO) has reported a 68% increase in E.P.S. from $1.86 a year ago to $3.13 in the current quarter. Relative to the consensus estimate […]
Gap Inc (NYSE: GAP) stock enjoyed a major increase of 18.8% on 3/7/25. The shares closed at $23.15. Moreover, trading volume in this advance was exceptionally high at 513% of normal. The stock has risen […]
Stock Rating Upgrade The Value Trend Rating for Fidus Investment Corp (NASDAQ: FDUS) improved in the last week from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are […]
Stock Rating Upgrade The Value Trend Rating for FARO Technologies Inc (NASDAQ: FARO) improved during the last several trading days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher […]
Stock Rating Downgrade In the last week the Value Trend Rating for EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action EyePoint Pharmaceuticals Inc […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research